GT Biopharma, Inc. (GTBP)

0.8175 +0.03 (+4.11%) USD  |  NASDAQ  |  Jan 02, 16:00
0.8175 0.00 (0.00%) After-Hours: 19:20
More

GT Biopharma Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for GTBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
SELLAS Life Sciences Group, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade